{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:08:10Z","timestamp":1783627690105,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004530","name":"Universiti Putra Malaysia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04592-z","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:59:10Z","timestamp":1758787150000},"page":"2969-2987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Synthesis of CNP-SAR405 delivery system for improved therapeutics anticancer activity using A549 human lung cancer cell lines"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7775-2161","authenticated-orcid":false,"given":"Ruqayyah A.","family":"Bashirah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6810-9466","authenticated-orcid":false,"given":"Nur Balqis","family":"Zamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1966-8580","authenticated-orcid":false,"given":"Noorjahan Banu","family":"Alitheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saila","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0695-2136","authenticated-orcid":false,"given":"Mas Jaffri","family":"Masarudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"4592_CR1","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.onano.2023.100142","volume":"11","author":"MN Alamassi","year":"2023","unstructured":"Alamassi MN, Chia SL, Abdullah CAC, Masarudin MJ (2023) Increased efficacy of biologics following inhibition of autophagy in A549 lung cancer cells in bimodal treatment of doxorubicin and SAR405-loaded chitosan nanoparticles. OpenNano 11:100142","journal-title":"OpenNano"},{"issue":"1","key":"4592_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","volume":"22","author":"ES Ali","year":"2022","unstructured":"Ali ES, Mitra K, Akter S, Ramproshad S, Mondal B, Khan IN et al (2022) Recent advances and limitations of mTOR inhibitors in the treatment of cancer. Cancer Cell Int 22(1):284","journal-title":"Cancer Cell Int"},{"key":"4592_CR3","doi-asserted-by":"publisher","first-page":"586069","DOI":"10.3389\/fonc.2020.586069","volume":"10","author":"JG Alvarez-Meythaler","year":"2020","unstructured":"Alvarez-Meythaler JG, Garcia-Mayea Y, Mir C, Kondoh H, LLeonart ME (2020) Autophagy takes center stage as a possible cancer hallmark. Front Oncol 10:586069. https:\/\/doi.org\/10.3389\/fonc.2020.586069","journal-title":"Front Oncol"},{"issue":"6","key":"4592_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30061297","volume":"30","author":"R Biswas","year":"2025","unstructured":"Biswas R, Mondal S, Ansari MA, Sarkar T, Condiuc IP, Trifas G et al (2025) Chitosan and its derivatives as nanocarriers for drug delivery. Molecules 30(6):1297","journal-title":"Molecules"},{"issue":"1","key":"4592_CR5","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1038\/s41467-020-18504-7","volume":"11","author":"N Gremke","year":"2020","unstructured":"Gremke N, Polo P, Dort A, Schneikert J, Elmsh\u00e4user S, Brehm C et al (2020) Mtor-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability. Nat Commun 11(1):4684","journal-title":"Nat Commun"},{"key":"4592_CR6","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.2147\/IJN.S164843","volume":"13","author":"UA Hassan","year":"2018","unstructured":"Hassan UA, Hussein MZ, Alitheen N, Yahya Ariff SA, Masarudin MJ (2018) In vitro cellular localization and efficient accumulation of fluorescently tagged biomaterials from monodispersed chitosan nanoparticles for elucidation of controlled release pathways for drug delivery systems. IJN 13:5075\u20135095","journal-title":"IJN"},{"issue":"11","key":"4592_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111775","volume":"11","author":"CJ Ho","year":"2019","unstructured":"Ho CJ, Gorski SM (2019) Molecular mechanisms underlying autophagy-mediated treatment resistance in cancer. Cancers 11(11):1775","journal-title":"Cancers"},{"key":"4592_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rsurfi.2025.100529","volume":"19","author":"S Islam","year":"2025","unstructured":"Islam S, Ahmed MMS, Islam MA, Hossain N, Chowdhury MA (2025) Advances in nanoparticles in targeted drug delivery\u2013a review. Results in Surfaces and Interfaces 19:100529","journal-title":"Results in Surfaces and Interfaces"},{"issue":"4","key":"4592_CR9","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3390\/molecules28041963","volume":"28","author":"K Jafernik","year":"2023","unstructured":"Jafernik K, \u0141adniak A, Blicharska E, Czarnek K, Ekiert H, Wi\u0105cek AE et al (2023) Chitosan-based nanoparticles as effective drug delivery systems\u2014a review. Molecules 28(4):1963","journal-title":"Molecules"},{"key":"4592_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1528230","volume":"16","author":"P Jalali","year":"2025","unstructured":"Jalali P, Shahmoradi A, Samii A, Mazloomnejad R, Hatamnejad MR, Saeed A et al (2025) The role of autophagy in cancer: from molecular mechanism to therapeutic window. Front Immunol 16:1528230","journal-title":"Front Immunol"},{"key":"4592_CR11","doi-asserted-by":"crossref","unstructured":"Jia B, Xue Y, Yan X, Li J, Wu Y, Guo R et al (2018) Autophagy inhibitor chloroquine induces apoptosis of cholangiocarcinoma cells via endoplasmic reticulum stress. Oncol Lett [Internet]. [cited 2025 Aug 18]; Available from: http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.9131","DOI":"10.3892\/ol.2018.9131"},{"issue":"7","key":"4592_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3390\/cells8070674","volume":"8","author":"R Khandia","year":"2019","unstructured":"Khandia R, Dadar M, Munjal A, Dhama K, Karthik K, Tiwari R et al (2019) A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy. Cells 8(7):674","journal-title":"Cells"},{"issue":"22","key":"4592_CR13","doi-asserted-by":"publisher","first-page":"13990","DOI":"10.3390\/ijms232213990","volume":"23","author":"GJ Kontoghiorghes","year":"2022","unstructured":"Kontoghiorghes GJ (2022) New iron metabolic pathways and chelation targeting strategies affecting the treatment of all types and stages of cancer. Int J Mol Sci 23(22):13990. https:\/\/doi.org\/10.3390\/ijms232213990","journal-title":"Int J Mol Sci"},{"key":"4592_CR14","doi-asserted-by":"crossref","unstructured":"Lendvai G, Szekercz\u00e9s T, Illy\u00e9s I, Csengeri M, Schlachter K, Szab\u00f3 E et al (2021) Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor. Trajkovic V, editor. PLoS ONE 16(6):e0253065","DOI":"10.1371\/journal.pone.0253065"},{"issue":"1","key":"4592_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03092-9","volume":"23","author":"H Liu","year":"2025","unstructured":"Liu H, Jin X, Liu S, Liu X, Pei X, Sun K et al (2025) Recent advances in self-targeting natural product-based nanomedicines. J Nanobiotechnol 23(1):31","journal-title":"J Nanobiotechnol"},{"key":"4592_CR16","doi-asserted-by":"publisher","unstructured":"Mahoutforoush S, Soltanfam T, Dehghan G, Ezzati Nazhad Dolatabadi J, Hamishehkar H (2022) Co-delivery of erlotinib and resveratrol via nanostructured lipid carriers: a synergistically promising approach for cell proliferation prevention and ROS-mediated apoptosis activation. Int J Pharm 624:122027.\u00a0https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122027","DOI":"10.1016\/j.ijpharm.2022.122027"},{"issue":"4","key":"4592_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.34172\/apb.2023.077","volume":"13","author":"A Mahoutforoush","year":"2023","unstructured":"Mahoutforoush A, Asadollahi L, Hamishehkar H, Abbaspour-Ravasjani S, Solouk A, Haghbin NM (2023) Targeted delivery of pennyroyal via methotrexate functionalized PEGylated nanostructured lipid carriers into breast cancer cells; a multiple pathways apoptosis activator. Adv Pharm Bull 13(4):747\u2013760","journal-title":"Adv Pharm Bull"},{"key":"4592_CR18","doi-asserted-by":"publisher","unstructured":"Masarudin MJ, Cutts SM, Evison BJ, Phillips DonR, Pigram PJ (2015) Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin. NSA\u00a0 67\u201380.\u00a0https:\/\/doi.org\/10.2147\/NSA.S91785","DOI":"10.2147\/NSA.S91785"},{"issue":"12","key":"4592_CR19","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1021\/acsptsci.4c00530","volume":"7","author":"D Mehta","year":"2024","unstructured":"Mehta D, Rajput K, Jain D, Bajaj A, Dasgupta U (2024) Unveiling the role of mechanistic target of rapamycin kinase (MTOR) signaling in cancer progression and the emergence of MTOR inhibitors as therapeutic strategies. ACS Pharmacol Transl Sci 7(12):3758\u20133779","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"4","key":"4592_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","volume":"9","author":"MA Mohammed","year":"2017","unstructured":"Mohammed MA, Syeda JTM, Wasan KM, Wasan EK (2017) An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics 9(4):53","journal-title":"Pharmaceutics"},{"issue":"3","key":"4592_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/ars.2013.5371","volume":"20","author":"KR Parzych","year":"2014","unstructured":"Parzych KR, Klionsky DJ (2014) An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal 20(3):460\u2013473","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"4592_CR22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/15548627.2015.1033601","volume":"11","author":"B Pasquier","year":"2015","unstructured":"Pasquier B (2015) SAR405, a PIK3C3\/Vps34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells. Autophagy 11(4):725\u2013726","journal-title":"Autophagy"},{"issue":"8","key":"4592_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.33545\/26174693.2024.v8.i8f.1767","volume":"8","author":"NK Pawaskar","year":"2024","unstructured":"Pawaskar NK, Kumar A, Gupta PK, Muneeb JM, Yadav S, Saini M et al (2024) Synthesis and characterization of chitosan nanoparticles: insights from in-vitro analysis. Int J Adv Biochem Res 8(8):421\u2013426","journal-title":"Int J Adv Biochem Res"},{"issue":"7737","key":"4592_CR24","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1038\/s41586-018-0815-6","volume":"565","author":"L Poillet-Perez","year":"2019","unstructured":"Poillet-Perez L, Xie X, Zhan L, Yang Y, Sharp DW, Hu ZS et al (2019) Author correction: Autophagy maintains tumour growth through circulating arginine. Nature 565(7737):E3\u2013E3","journal-title":"Nature"},{"issue":"4","key":"4592_CR25","doi-asserted-by":"publisher","first-page":"e42450","DOI":"10.1016\/j.heliyon.2025.e42450","volume":"11","author":"M Ray","year":"2025","unstructured":"Ray M, Al Hoque A, Chatterjee S, Adhikary S, Paul S, Mukherjee B et al (2025) Clofarabine-loaded aptamer-conjugated biodegradable nanoparticle successfully targeted CD117 overexpressed HL60 cells and potentially induced apoptosis. Heliyon 11(4):e42450","journal-title":"Heliyon"},{"key":"4592_CR26","doi-asserted-by":"publisher","first-page":"27494","DOI":"10.1038\/srep27494","volume":"6","author":"JD Robertson","year":"2016","unstructured":"Robertson JD, Rizzello L, Avila-Olias M, Gaitzsch J, Contini C, Mago\u0144 MS, Renshaw SA, Battaglia G (2016) Purification of nanoparticles by size and shape. Sci Rep 6:27494. https:\/\/doi.org\/10.1038\/srep27494","journal-title":"Sci Rep"},{"issue":"4","key":"4592_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/md21040211","volume":"21","author":"B Sachdeva","year":"2023","unstructured":"Sachdeva B, Sachdeva P, Negi A, Ghosh S, Han S, Dewanjee S et al (2023) Chitosan nanoparticles-based cancer drug delivery: application and challenges. Mar Drugs 21(4):211","journal-title":"Mar Drugs"},{"issue":"7","key":"4592_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrd3499","volume":"10","author":"JW Yoo","year":"2011","unstructured":"Yoo JW, Irvine DJ, Discher DE, Mitragotri S (2011) Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov 10(7):521\u2013535","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"4592_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091865","volume":"18","author":"SR Yoshii","year":"2017","unstructured":"Yoshii SR, Mizushima N (2017) Monitoring and measuring autophagy. Int J Mol Sci 18(9):1865","journal-title":"Int J Mol Sci"},{"issue":"13","key":"4592_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.966012","volume":"11","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhu Y, Zhang J, Zhang L, Chen L (2022) Inhibiting cytoprotective autophagy in cancer therapy: an update on pharmacological small-molecule compounds. Front Pharmacol 11(13):966012","journal-title":"Front Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04592-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04592-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04592-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:56:39Z","timestamp":1770882999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04592-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4592"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04592-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable \u2013 the study used established human cell lines and does not involve animals or patient material.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.\nThe authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}